| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22b01638aca886e92aa6900d00836006 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-238
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49 |
| filingDate |
2015-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d839339946d4ac3f90d1b1e6bf0ba8f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eacf654836dfaddf497e5fd4ec22fbca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86ecd96f01776eb0bf8d0940fc7ee2c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c60a51aa2f66eb685cbfc13038aa2550 |
| publicationDate |
2017-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2017066050-A |
| titleOfInvention |
Saccharification product formation inhibitor |
| abstract |
Disclosed is a terminal glycation product production inhibitor. Disclosed is a terminal glycation product production inhibitor containing a shimifugin derivative as an active ingredient. The shimifugin derivative is suitably used for the prevention and / or treatment of diabetes or diabetic complications and the prevention and / or improvement of skin aging due to its inhibitory action on the production of advanced glycation end products. [Selection figure] None |
| priorityDate |
2015-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |